396 related articles for article (PubMed ID: 18772488)
1. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance.
Traish AM; Saad F; Guay A
J Androl; 2009; 30(1):23-32. PubMed ID: 18772488
[TBL] [Abstract][Full Text] [Related]
2. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
Traish AM; Guay A; Feeley R; Saad F
J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
[TBL] [Abstract][Full Text] [Related]
3. The dark side of testosterone deficiency: III. Cardiovascular disease.
Traish AM; Saad F; Feeley RJ; Guay A
J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
[TBL] [Abstract][Full Text] [Related]
4. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
Guay AT; Traish A
Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
[TBL] [Abstract][Full Text] [Related]
5. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency.
Boyanov MA; Boneva Z; Christov VG
Aging Male; 2003 Mar; 6(1):1-7. PubMed ID: 12809074
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
Corona G; Mannucci E; Forti G; Maggi M
Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
[TBL] [Abstract][Full Text] [Related]
7. The emerging link between hypogonadism and metabolic syndrome.
Guay AT
J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
[TBL] [Abstract][Full Text] [Related]
8. Androgens, insulin resistance and vascular disease in men.
Kapoor D; Malkin CJ; Channer KS; Jones TH
Clin Endocrinol (Oxf); 2005 Sep; 63(3):239-50. PubMed ID: 16117808
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of androgen deficiency in men with erectile dysfunction.
Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
[TBL] [Abstract][Full Text] [Related]
10. Testosterone deficiency and the metabolic syndrome.
Lunenfeld B
Aging Male; 2007 Jun; 10(2):53-6. PubMed ID: 17558968
[TBL] [Abstract][Full Text] [Related]
11. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
Corona G; Mannucci E; Forti G; Maggi M
Int J Androl; 2009 Oct; 32(5):431-41. PubMed ID: 19538523
[TBL] [Abstract][Full Text] [Related]
12. Testosterone and type 2 diabetes.
Grossmann M; Gianatti EJ; Zajac JD
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):247-56. PubMed ID: 20418720
[TBL] [Abstract][Full Text] [Related]
13. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.
Corona G; Forti G; Maggi M
Aging Male; 2008 Dec; 11(4):193-9. PubMed ID: 19172551
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction.
Traish AM; Feeley RJ; Guay A
FEBS J; 2009 Oct; 276(20):5755-67. PubMed ID: 19754871
[TBL] [Abstract][Full Text] [Related]
15. [Androgen deficit and diabetes].
Cáp J
Vnitr Lek; 2012 Mar; 58(3):228-31. PubMed ID: 22486290
[TBL] [Abstract][Full Text] [Related]
16. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control.
El-Sakka AI; Sayed HM; Tayeb KA
Urology; 2009 Sep; 74(3):552-9. PubMed ID: 19592073
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
[TBL] [Abstract][Full Text] [Related]
18. Metabolic rate and vascular function are reduced in women with a family history of type 2 diabetes mellitus.
Olive JL; Ballard KD; Miller JJ; Milliner BA
Metabolism; 2008 Jun; 57(6):831-7. PubMed ID: 18502267
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction.
El-Sakka AI; Sayed HM; Tayeb KA
Int J Androl; 2008 Dec; 31(6):602-8. PubMed ID: 17877718
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
